Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Cash Interest Paid
|
Sonoma Pharmaceuticals Inc
Cash Interest Paid Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Cash Interest Paid
$25k
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-22%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash Interest Paid
$308m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash Interest Paid
$2.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash Interest Paid
$1.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Sonoma Pharmaceuticals Inc's Cash Interest Paid?
Cash Interest Paid
25k
USD
25k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Cash Interest Paid amounts to 25k USD.
What is Sonoma Pharmaceuticals Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
-22%
-22%
Over the last year, the Cash Interest Paid growth was 25%. The average annual Cash Interest Paid growth rates for Sonoma Pharmaceuticals Inc have been -6% over the past three years , -9% over the past five years , and -22% over the past ten years .
You don't have any saved screeners yet
